Vicarious Surgical (NYSE:RBOT) PT Lowered to $5.00

Vicarious Surgical (NYSE:RBOT – Get Rating) had its price target lowered by Piper Sandler from $7.00 to $5.00 in a research note published on Tuesday, The Fly reports.

Separately, Zacks Investment Research downgraded Vicarious Surgical from a hold rating to a sell rating in a research note on Thursday, May 5th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of Buy and a consensus price target of $11.63.

Vicarious Surgical stock opened at $3.93 on Tuesday. The stock has a 50 day moving average of $4.70 and a 200-day moving average of $7.63. Vicarious Surgical has a 52 week low of $3.05 and a 52 week high of $15.79.

Vicarious Surgical (NYSE:RBOT – Get Rating) last issued its earnings results on Thursday, March 3rd. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.04). As a group, analysts forecast that Vicarious Surgical will post -0.57 earnings per share for the current year.

In other Vicarious Surgical news, CTO Sammy Khalifa sold 6,830 shares of the business’s stock in a transaction on Thursday, April 14th. The stock was sold at an average price of $4.08, for a total value of $27,866.40. Following the transaction, the chief technology officer now owns 136,413 shares of the company’s stock, valued at $556,565.04. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Adam David Sachs sold 8,537 shares of the business’s stock in a transaction on Monday, March 28th. The stock was sold at an average price of $4.23, for a total value of $36,111.51. The disclosure for this sale can be found here. In the last ninety days, insiders sold 35,842 shares of company stock worth $152,359.

Hedge funds have recently added to or reduced their stakes in the company. Nauset Wealth Management. LLC bought a new stake in shares of Vicarious Surgical during the first quarter worth $26,000. Advisor Group Holdings Inc. bought a new stake in shares of Vicarious Surgical during the third quarter worth $27,000. BlackRock Inc. bought a new stake in shares of Vicarious Surgical during the third quarter worth $32,000. Citigroup Inc. bought a new stake in shares of Vicarious Surgical during the fourth quarter worth $47,000. Finally, Wolverine Asset Management LLC raised its position in shares of Vicarious Surgical by 165.7% during the first quarter. Wolverine Asset Management LLC now owns 10,147 shares of the company’s stock worth $51,000 after acquiring an additional 6,328 shares during the last quarter. Institutional investors own 35.25% of the company’s stock.

Vicarious Surgical Company Profile (Get Rating)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Featured Stories